title: [Development of DRGs in reconstructive breast surgery].
abstract: Diagnosis-Related Groups (DRG) were introduced in Germany in 2004 as a medico-economic classification system. In this analysis, we looked at reconstructive surgery after breast cancer, focusing on changes of the fee-per-case system in the last 6 years. Immediate, delayed, pedicle and free flaps as well as alloplastic reconstructive methods were analysed using data from German reference hospitals. We analysed the length of stay, reimbursements, costs and profits. The biggest profit margin was found in free perforator flaps. These were up to 3 times higher than in alloplastic reconstruction and pedicle flaps. Due to the fact that the underlying costs for the calculation of reimbursement are always retrospective, we accounted for the rate of price increase. In spite of increasing mean profits, foregone profits of up to €574 per case due to inflation were not taken into consideration. Contrary to actual guidelines, neither the immediate reconstruction of the breast by autologous tissue, nor the bilateral reconstruction is taken into account economically. Although a more differentiated reimbursement of breast reconstruction by DRG has taken place in the last years, the subject still remains a classical example for insufficient mapping of new medical standards in our DRG system. As the choice of surgical therapy is increasingly influenced by free market mechanisms, the risk for economic selection in contradiction to clinical recommendations becomes a real problem. Even 9 years after its introduction, the German DRG system is far from being a learning or quick adapting system.
authors.affiliation: Klinik für Hand-, Plastische Rekonstruktive und Verbrennungschirurgie an der Eberhard-Karls-Universität Tübingen, Berufsgenossenschaftliche Unfallklinik. oliver.lotter@freenet.de
authors.forename: O
authors.initials: O
authors.lastname: Lotter
authors.forename: A
authors.initials: A
authors.lastname: Amr
authors.forename: P
authors.initials: P
authors.lastname: Jaminet
authors.forename: S
authors.initials: S
authors.lastname: Hoefert
authors.forename: H-E
authors.initials: HE
authors.lastname: Schaller
authors.forename: S
authors.initials: S
authors.lastname: Stahl
mesh_terms: D017046:Cost Savings; D003953:Diagnosis-Related Groups / Q000191:economics*; D005260:Female; D005858:Germany; D017721:Hospital Costs / Q000706:statistics & numerical data; D006801:Humans; D007902:Length of Stay / Q000191:economics; D016462:Mammaplasty / Q000191:economics*; D009313:National Health Programs / Q000191:economics*; D011785:Quality Assurance, Health Care / Q000191:economics; D012051:Reimbursement Mechanisms / Q000191:economics*